PAPER Kuznetsova E, Schliebs R
SEARCH RESULTS
332292 RESULTS
PAPER Dos Santos VV, Rodrigues AL, De Lima TC, de Barioglio SR, Raisman-Vozari R, Prediger RD
Ghrelin As A Neuroprotective And Palliative Agent In Alzheimer's And Parkinson's Disease.
Curr Pharm Des. 2013 Mar 19; PubMed.PAPER Correia SC, Carvalho C, Cardoso S, Santos RX, Plácido AI, Candeias E, Duarte AI, Moreira PI
Defective HIF Signaling Pathway And Brain Response To Hypoxia In Neurodegenerative Diseases: Not An "Iffy" Question!
Curr Pharm Des. 2013 Mar 19; PubMed.PAPER Kapoor A, Wang BJ, Hsu WM, Chang MY, Liang SM, Liao YF
Retinoic Acid-Elicited RARα/RXRα Signaling Attenuates Aβ Production by Directly Inhibiting γ-Secretase-Mediated Cleavage of Amyloid Precursor Protein.
ACS Chem Neurosci. 2013 Apr 15; PubMed.PAPER Darusman HS, Sajuthi D, Kalliokoski O, Jacobsen KR, Call J, Schapiro SJ, Gjedde A, Abelson KS, Hau J
Correlations between serum levels of beta amyloid, cerebrospinal levels of tau and phospho tau, and delayed response tasks in young and aged cynomolgus monkeys (Macaca fascicularis).
J Med Primatol. 2013 Jun;42(3):137-46. PubMed.PAPER Hayes CD, Dey D, Palavicini JP, Wang H, Patkar KA, Minond D, Nefzi A, Lakshmana MK
Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine.
BMC Med. 2013;11:81. PubMed.PAPER Chong SH, Ham S
Conformational entropy of intrinsically disordered protein.
J Phys Chem B. 2013 May 9;117(18):5503-9. PubMed.PAPER Araki W
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease.
BMC Med. 2013;11:82. PubMed.PAPER Semar S, Klotz M, Letiembre M, Van Ginneken C, Braun A, Jost V, Bischof M, Lammers WJ, Liu Y, Fassbender K, Wyss-Coray T, Kirchhoff F, Schäfer KH
Changes of the Enteric Nervous System in Amyloid-β Protein Precursor Transgenic Mice Correlate with Disease Progression.
J Alzheimers Dis. 2013 Jan 1;36(1):7-20. PubMed.PAPER George RC, Lew J, Graves DJ
Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer's disease pathogenesis.
J Alzheimers Dis. 2013 Jan 1;36(1):21-40. PubMed.PAPER Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV
Microglia activation as a biomarker for traumatic brain injury.
Front Neurol. 2013;4:30. PubMed.PAPER Barker R, Wellington D, Esiri MM, Love S
Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.
J Cereb Blood Flow Metab. 2013 Mar 27; PubMed.PAPER Kurinami H, Shimamura M, Sato N, Nakagami H, Morishita R
Do Angiotensin receptor blockers protect against Alzheimer's disease?
Drugs Aging. 2013 Jun;30(6):367-72. PubMed.PAPER Maarouf CL, Beach TG, Adler CH, Malek-Ahmadi M, Kokjohn TA, Dugger BN, Walker DG, Shill HA, Jacobson SA, Sabbagh MN, Roher AE,
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.
Biomark Insights. 2013;8:19-28. PubMed.PAPER Liu GT, Hwang CS, Hsieh CH, Lu CH, Chang SL, Lee JC, Huang CF, Chang HT
Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.
Mediators Inflamm. 2013;2013:421389. PubMed.Current Filters
No filters selected